Neurones (NRO) Q1 2026 TU earnings summary

Executive summary

• Achieved 5.6% organic revenue growth in Q1 2026, driven by Cloud, digital projects, SAP, Data & AI initiatives.

• Operating profit increased to 9% of revenues, up from 8.2% in Q1 2025.

Financial highlights

• Q1 2026 revenues reached €227.7 million, up 6.3% year-over-year.

• Organic revenue growth was 5.6% compared to Q1 2025.

• Operating profit margin improved to 9% of revenues.

Outlook and guidance

• Full-year 2026 revenue forecast is around €900 million.

• Operating profit expected to be approximately 9% for the year, excluding economic uncertainties.